Amylyx Pharmaceuticals Overview
Amylyx Pharmaceuticals Target Price
Analysts' 12-month price predictions for AMLX.
Get informed when a big investor buys or sells
+ FollowShare Price
$18.2
Average Target Price
$31.67
74% upside
74% upside3 analysts in the last 4 months
High: $40 | Low: $21
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-25 | Guggenheim | $40 | 119.8% upside |  |
| 2026-06-08 | H.C. WainwrightAndrew Fein | $34 | 86.8% upside | |
| 2026-04-28 | Mizuho SecuritiesGraig Suvannavejh | $21 | 15.4% upside | |
| 2026-02-19 | Mizuho Securities | $19 | 4.4% upside | |
| 2026-02-10 | H.C. WainwrightAndrew Fein | $28 | 53.8% upside | |
| 2025-10-29 | Mizuho Securities | $16 |  12.1% downside | |
| 2025-10-16 | Robert W. BairdJoel Beatty | $19 | 4.4% upside | |
| 2025-09-15 | GuggenheimSeamus Fernandez | $25 | 37.4% upside | |
| 2025-06-24 | GuggenheimSeamus Fernandez | $17 | 6.6% downside | |
| 2025-05-06 | Leerink PartnersMarc Goodman | $10 | 45.1% downside | |
| 2024-11-18 | Robert W. BairdJoel Beatty | $11 | 39.6% downside | |
| 2024-10-23 | Bank of America SecuritiesGeoff Meacham | $10 | 45.1% downside | |
| 2024-10-18 | H.C. WainwrightAndrew Fein | $8 | 56% downside | |
| 2024-10-18 | Leerink PartnersMarc Goodman | $4 | 78% downside | |
| 2024-05-14 | Mizuho SecuritiesGraig Suvannavejh | $3 | 83.5% downside | |
| 2024-04-11 | Robert W. BairdJoel Beatty | $3 | 83.5% downside | |
| 2024-04-04 | Deutsche BankNeena Bitritto-Garg | $4 | 78% downside | |
| 2024-03-17 | Mizuho SecuritiesGraig Suvannavejh | $4 | 78% downside | |